Sage Mountain Advisors’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-86,890
| Closed | -$860K | – | 552 |
|
|
2022
Q2 | $860K | Sell |
86,890
-7,750
| -8% | -$76.7K | 0.15% | 115 |
|
|
2022
Q1 | $933K | Sell |
94,640
-2,000
| -2% | -$19.7K | 0.15% | 122 |
|
|
2021
Q4 | $964K | Sell |
96,640
-1,980
| -2% | -$19.8K | 0.12% | 145 |
|
|
2021
Q3 | $977K | Buy |
98,620
+2,650
| +3% | +$26.3K | 0.14% | 128 |
|
|
2021
Q2 | $979K | Hold |
95,970
| – | – | 0.16% | 115 |
|
|
2021
Q1 | $965K | Hold |
95,970
| – | – | 0.21% | 81 |
|
|
2020
Q4 | $1.02M | Buy |
+95,970
| New | +$1.02M | 0.33% | 46 |
|